LMAT (LeMaitre Vascular) Beta: 0.8520 (As of Jul. 06, 2026)


LMAT LeMaitre Vascular Inc LMAT
96 GF Score
Price $105.08
GF Value $97.30
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is LeMaitre Vascular Beta?

LeMaitre Vascular LMAT +2.14% 96 Beta is 0.8520 as of Jul. 06, 2026. GuruFocus rates LMAT with a GF Score™ of 96/100 and a GF Value™ of $97.30 (Fairly Valued). The stock has 1 warning sign investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-06), LeMaitre Vascular's Beta is 0.8520.


LeMaitre Vascular  (NAS:LMAT) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


LeMaitre Vascular Beta Related Terms


LeMaitre Vascular Beta Historical Data

* Premium members only.

The historical data trend for LeMaitre Vascular's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LeMaitre Vascular Beta Chart

LeMaitre Vascular Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.15 0.80 0.46 0.79 1.25

LeMaitre Vascular Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.84 0.76 0.89 1.25 1.05

LMAT vs XRAY, PLSE, KMTS: Beta Comparison

For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LeMaitre Vascular Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Beta distribution charts can be found below:

* The bar in red indicates where LeMaitre Vascular's Beta falls into.


LMAT
96GF Score
LeMaitre Vascular Inc LMAT
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LeMaitre Vascular Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.8520 mean?
LeMaitre Vascular (LMAT) has a Beta of 0.8520 as of Jul. 06, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for LeMaitre Vascular and its competitors.
Is LeMaitre Vascular's Beta too high?
LeMaitre Vascular's current Beta is 0.8520. Overall, LeMaitre Vascular has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does LeMaitre Vascular's Beta compare to XRAY and PLSE?
LeMaitre Vascular's Beta of 0.8520 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for LeMaitre Vascular and its competitors. LeMaitre Vascular's current Beta is 0.8520. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LeMaitre Vascular stock overvalued right now?
Based on GuruFocus' analysis, LeMaitre Vascular (LMAT) is currently considered Fairly Valued. The stock's GF Value™ is $97.30, compared to a current price of $105.08 — trading 8% above its estimated fair value. The current Beta is 0.8520. LeMaitre Vascular's overall GF Score™ is 96/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For LeMaitre Vascular (LMAT), the current Beta is 0.8520 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LeMaitre Vascular (LMAT) Overvalued in 2026?

Based on GuruFocus' analysis, LeMaitre Vascular stock appears to be overvalued. The current stock price of $105.08 is trading 8% above its estimated GF Value™ of $97.30. GuruFocus considers LeMaitre Vascular to be Fairly Valued.

Key valuation signals for LMAT:

  • Beta: 0.8520
  • GF Value™: $97.30 vs. price of $105.08 (8% above fair value)
  • GF Score™: 96/100 with 1 warning sign

No single metric tells the full story. See the LMAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LeMaitre Vascular Business Description

Other Exchanges LHU:Germany
Address 63 Second Avenue, Burlington, MA, USA, 01803
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
96GF Score

Get the complete analysis for LMAT

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$105.08
Price
$97.30
GF Value